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Abstract
Background
Meconium aspiration syndrome (MAS) is considered a major cause of respiratory morbidity. It
is a common issue encountered in the delivery room and newborn nursery. There is a need to
identify the factors that lead to MAS to develop strategies to screen such patients at an early
stage to decrease the mortality and morbidity. The objective of this study was to determine the
factors leading to MAS in neonates delivered at ≥37 weeks of gestational age.
Methods
A cross-sectional study was conducted through non-probability consecutive sampling
technique at Liaquat University Hospital, Hyderabad from August 2016 to February 2017. All
neonates at ≥37 weeks of gestation with meconium-stained amniotic fluid (MSAF) detected
during delivery were included in this study after obtaining informed consent from their parents.
The demographic and factors related to MAS were recorded through predesigned proforma and
analyzed using SPSS version 22. Mean and standard deviation were determined for quantitative
variables whereas frequency and percentages were calculated for qualitative variables.
Results
Overall 136 neonates were included in the study. The mean gestational age was 38 ± 1.43 weeks.
The major factors for MAS were detected as fetal distress (67.0%, n = 91), non-reassuring fetal
heart rate (54.0%, n = 73), cesarean birth (48.0%, n = 65), intrauterine growth restriction (IUGR;
17.0%, n = 23), and post maturity (12.0%, n = 16).
Conclusion
We conclude that the major factors for MAS are fetal distress, non-reassuring FHR tracing,
cesarean birth, IUGR, and post maturity. Screening of such patients at an early stage may
minimize morbidity and mortality related to MAS.
Categories: Obstetrics/Gynecology, Pediatrics
Keywords: meconium aspiration syndrome, fetal distress, intrauterine growth restriction, non-
reassuring fetal heart rate
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Meconium aspiration syndrome (MAS) is an illness of the term and near-term newborn, which
is associated with significant respiratory morbidity [1]. MAS is a common issue that most
pediatricians experience in the delivery room and ordinary newborn nursery [1]. Passage of
meconium-stained amniotic liquid (MSAF) during labor is estimated to occur at 12% to 15% in
every live birth [2]. This figure is up to 24% in deliveries with maternal complications [3].
MAS occurs in around 5% of these pregnancies [2]. The figure has declined considerably from
the earlier 22%, particularly in developed countries, accompanied by advances in obstetrics and
neonatal care.
A study in an urban Pakistani population showed 27.3% of neonatal mortality, where there was
a history or evidence of meconium passage during delivery [4]. It is as yet a noteworthy cause of
mortality and morbidity in the developing nations [5]. With this in perspective Pakistan also
has a high neonatal mortality rate (NMR) of 46 per 1000 live births [6]. The major risk factors for
meconium-stained amniotic liquid (MSAF) and MAS include post maturity in 34% of cases,
presence of fetal heart rate (FHR) irregularities in the intrapartum period in 51% of cases,
cesarean birth in 42% cases, fetal distress in 77%, and intrauterine growth restriction (IUGR) in
6% of cases [1].
The rationale of the study that even after a robust search, no local data were found on factors
leading to MAS and recent international data are scarce too; therefore, the present study was
designed to generate local data. Hence, strategies could be devised to screen such patients at an
early stage so that prompt intervention may halt or minimize morbidity and mortality related
to MAS.
Materials And Methods
This cross-sectional study was conducted at the Liaquat University Hospital, Hyderabad from
August 2016 to February 2017. A total of 136 neonates with gestational age equal to or greater
than 37 weeks and who were born with meconium-stained liquor were included. Meconium-
stained liquor is defined as the presence of meconium in amniotic fluid with a greenish or
yellow discoloration of fluid. Inclusion criteria were a baby born to mother with a singleton
pregnancy, gestational age equal to or greater than 37 weeks assessed on dating scan, and
MSAF detected during delivery. Preterm babies with gestation <37 weeks, previous cesarean
section, non-cephalic presentation, multiple pregnancies, congenital malformation, and
intrauterine fetal demise were excluded. This study was conducted after the permission of the
Ethical Committee of the hospital. Babies born with MSAF diagnosed during labor or delivery at
the Liaquat University Hospital, Hyderabad were enrolled in this study. Prior to inclusion,
informed consent for the study was obtained from the parents of eligible candidates. Data were
collected on a predesigned proforma to assess the factors leading to MAS which included
gestational age, mode of delivery, fetal distress, IUGR, non-reassuring CTG, gestational age on
dating scan, fetal distress defined as APGAR score <7 at five minutes, and IUGR defined by fetal
weight below the 10th percentile for gestational age after 24th week of gestation as determined
through an ultrasound. Fetal heart tracing was evaluated, and non-reassuring fetal heart rate
tracing was defined by either baseline bradycardia <110 or tachycardia >160 bpm, moderate to
severe variable deceleration, late decelerations, loss of beat to beat variability, and prolonged
fetal bradycardia. Finally, the child was labeled with MAS by defining MSAF in trachea assessed
on suction and confirmed on chest X-rays showing overinflation of lungs with multiple
opacities and flattening of the diaphragm.
After data collection, data were analyzed using Statistical Package for Social Science (SPSS)
programming, Version 22. The mean and standard deviation were determined for quantitative
factors like gestational age, APGAR score, and birth weight, and frequencies were calculated for
mode of delivery (cesarean/vaginal delivery), presence of IUGR finding on last ultrasound, non-
reassuring FHR, fetal distress, comorbidities of mother like history of hypertension, and
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diabetes mellitus. Impact modifiers such as gestational age and comorbidities such as infant of
diabetic mother and hypertension were constrained by stratification and Chi-square
test/Fischer exact test was conducted to understand the impact of these on result variables. P
≤0.05 was taken as significant.
Results
A total of 136 neonates identified with MSAF were included in this study. Mean gestational age
was 38 ±1.43, mean APGAR at five minutes and birth weight is also presented in (Table 1).
Infants of a diabetic mother were 10 (7%) and 23 (17%) were born to mothers with a history of
hypertension during pregnancy, as shown in Table 1.
 Mean (SD) Frequency (%)
Gestational age (weeks) 38.01 (±1.43)  
APGAR score at 5 minutes 6.29 (±1.43)  
Birth weight (kg) 2.53 (±0.24)  
Infant of a diabetic mother  10 (7%)
Maternal hypertension  23 (17%)
TABLE 1: Demographics
In our cohort of 136 patients with meconium stained amniotic fluid, we found that 120 (88%) of
the patients had a gestational age of 37-40 weeks, while 16 (12%) had a gestational age of > 40
weeks. (Table 2).
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Factors Frequency (percentages)
Gestational age
>40  weeks 16 (12%)
37-40 weeks 120 (88%)
Mode of delivery
Cesarean section 65 (48%)
Vaginal delivery 71 (52%)
Fetal distress 91 (67%)
Intrauterine growth restriction 23 (17%)
Non-reassuring FHR tracing 73 (54%)
TABLE 2: Frequency and percentages of various risk factors leading to meconium
aspiration syndrome
FHR, fetal heart rate
The major factors for MAS include non-reassuring FHR tracing found in 54% cases, cesarean
birth in 48% cases, fetal distress in 67% of cases, IUGR in 16.9%, and post maturity (gestational
age >40 weeks) in 11.8% of cases. The factors leading to MAS in neonates delivered at ≥37 weeks
of gestation with respect to gestational age, maternal hypertension, and diabetes status are




37 to 40 >40
Mode of delivery  
Cesarean section 49 (40.8%)  16 (100%)  
<0.05
Vaginal delivery 71 (59.2%) 0 (0%)
Fetal distress 75 (62.5%) 16 (100%) 0.001
Intrauterine growth restriction 20 (16.7%) 3 (18.8%) 0.835
Non-reassuring FHR tracing 60 (50%) 13 (81.3%) 0.019
TABLE 3: Association of gestational age with factors leading to meconium aspiration
syndrome
FHR, fetal heart rate
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Factors
Infant of diabetic mother
P-Value
Yes No
Gestational age >40 weeks 1 (10%) 15 (11.9%) 0.85
Mode of delivery
Cesarean section 3 (30%) 62 (49.2%)
0.33
Vaginal delivery 7 (70%) 64 (50.8%)
Fetal distress 6 (60%) 85 (67.5%) 0.73
Intrauterine growth restriction 1 (10%) 22 (17.5%) 0.54
Non-reassuring FHR tracing 3 (30%) 70 (55.6%) 0.119
TABLE 4: Association of infant of diabetic mother with factors leading to meconium
aspiration syndrome





Gestational age >40 weeks 3 (13%) 13 (11.5%) 0.835
Mode of delivery
Cesarean section 9 (39.1%) 56 (49.6%)
0.361
Vaginal delivery 14 (60.9%) 57 (50.4%)
Fetal distress 17 (73.9%) 74 (65.5%) 0.434
Intrauterine growth restriction 4 (17.4%) 19 (16.8%) 0.946
Non-reassuring FHR tracing 13 (56.5%) 60 (53.1%) 0.764
TABLE 5: Association of maternal hypertension with factors leading to meconium
aspiration syndrome
FHR, fetal heart rate
Discussion
The passage of MSAF during labor is reported to occur in 12% to 15% of all live births [4,7-8].
This figure is higher in deliveries associated with maternal complications (up to 24%) [3,9].
MAS occurs in around 5% of these pregnancies [2,9]. The figure has declined substantially from
the earlier reported figure of 22%, especially in developed countries, accompanied by advances
in obstetrics and neonatal care [8].
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Pakistan’s NMR is 46 deaths per 1,000 live births [6]. According to a study in an urban Pakistani
population, 27.3% of neonatal deaths had a history or evidence of meconium passage during
delivery [9].
When exposed to stress such as hypoxia, fetus passes meconium and starts reflex gasping, a
combination which allows meconium to reach the respiratory airways. The meconium then
affects the respiratory system by mechanical airway obstruction, pneumonitis, and surfactant
inactivation. All of these contribute to persistent pulmonary hypertension of the newborn
(PPHN), which is the final common pathway for the severe morbidity and mortality seen in
infants with MAS [3]. Meconium aspiration can present a diverse clinical spectrum ranging
from mild self-resolving respiratory distress to severe respiratory failure resulting in severe
morbidity and mortality. Severe meconium aspiration is also known to be associated with long-
term abnormal respiratory reactivity [8]. The degree to which meconium has reached distal
airways by the time of birth and the effect of meconium suction immediately after birth in
preventing the severe clinical course are still controversial.
In the present study, major factors for MSAF-MAS include non-reassuring FHR tracing found in
53.7% cases, 47.8% cesarean birth, fetal distress in 66.9% of cases, IUGR in 16.9% cases, and
post maturity (gestational age >40 weeks) in 11.8% of cases. Similar results were also reported
in a study that stated major risk factors for MAS include post maturity in 34% of cases, presence
of fetal heart rate abnormalities in the intrapartum period in 51% of cases, 42% in cesarean
birth, fetal distress in 77% of cases and IUGR in 6% and maternal ethnicity (African American,
Pacific Islanders) [1]. 
The relationship between the event of MSAF and fetal distress has been accounted for by many
authors [10]. In a study by Yoder, infants with moderate to thick MSAF had substantially
increased the occurrence of factors, suggestive of intrapartum compromise (irregular fetal
heart pattern, fetal acidosis) in contrast with infants without MSAF and newborn children with
light meconium staining of AF (P < 0.01) [11]. In a study by Berkus et al., the moderate and thick
meconium groups had fundamentally higher danger of an unusual fetal heart rate tracing in
each phase of labor and cord blood vessel pH under 7.20 (marker of fetal compromise)
contrasting with the thin meconium and clear amniotic fluid (CAF) groups combined [12].
However, a study from Hyderabad, Pakistan refers to meconium being documented in 27.3% of
neonatal deaths [4]. The study center was unable to offer proper mechanical ventilation to all
the babies. Lack of ventilators combined with over-crowding, over-worked and inadequate
staffing and inadequate or improper perinatal services are the main factors that need to be
addressed [4,13-14]. Higher mortality in hospital-based studies usually mirrors the high-risk
population, but comparative figures for developed countries are much lower.
Conclusions
In this study, the major factors for MSAF and MAS include non-reassuring FHR tracing,
cesarean birth, fetal distress, IUGR, and post maturity. MAS remains an important cause of
morbidity as well as mortality in term and post-term newborns. In order to reduce the mortality
and morbidity associated with MAS, strategies should be devised to screen such patients at an
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